Answers are grounded in this paper and cite their sources.
Review demonstrates endoscopic resection and ablation replacing surgery for esophageal cancer, indicating a shift toward organ-sparing multimodal care.
Treatment of esophageal cancer, owing to its clinically challenging nature, requires a multimodal strategy. Over the next 10 years, it is expected to become a more common health problem. The incidence of squamous cell carcinoma (SCC) is consistently increasing, and this can be largely attributed to risk factors such as smoking and the use of antacids; also greater utilization of endoscopy has been observed for multiple reasons, such as screening and monitoring. Endoscopic methods that involve combining radiofrequency ablation with endoscopic mucosal resection or dissection have now taken over esophagectomy as the preferred initial treatment. Modern therapy comprises three fundamental approaches: surgery, radiation, and chemotherapy. TP53 and cell cycle controllers are considered the primary sources of endoscopic therapeutic knowledge and have been utilized as tumor markers for treating other malignancies.
No takes yet. Share an insight, caveat, or question.
Sawarkar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: